Francine R. Wilson
CSL (United States)(US)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, Hemoglobinopathies and Related Disorders, Computational Drug Discovery Methods, Cancer-related Molecular Pathways, Ubiquitin and proteasome pathways
Most-Cited Works
- → Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice.(1994)285 cited
- → Specific inhibition of cyclooxygenase‐2 with MK‐0966 is associated with less gastroduodenal damage than either aspirin or ibuprofen(1999)170 cited
- → 2-Substituted Piperazines as Constrained Amino Acids. Application to the Synthesis of Potent, Non Carboxylic Acid Inhibitors of Farnesyltransferase(1996)50 cited
- → Cloning and sequencing of a [NiFe] hydrogenase operon from Desulfovibrio vulgaris Miyazaki F(1990)49 cited
- → N-Arylpiperazinone Inhibitors of Farnesyltransferase: Discovery and Biological Activity(1999)45 cited
- → Clavaric Acid and Steroidal Analogues as Ras- and FPP-Directed Inhibitors of Human Farnesyl-Protein Transferase(1998)33 cited
- → [38] Inhibition of Ras function in Vitro and in Vivo using inhibitors of farnesyl-protein transferase(1995)9 cited
- → Phase 1 Study of the Safety and Pharmacokinetics of CSL889 (Hemopexin) in Adults with SCD(2024)4 cited
- → Design of the RHEMEDY Study: A Phase 2/3 Safety, Efficacy and Pharmacokinetics Study of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis(2025)
- → Phase I study of the safety and pharmacokinetics of CSL889 (hemopexin) in adults with sickle cell anemia(2026)